5d
Stockhead on MSNDr Boreham’s Crucible: What’s all the fuss about biotech behemoth CSL?While still robust, CSL half-year results last Weds revealed impact of an “alarming” fall off in 'flu vax rates, especially ...
A weak vaccine result dragged on CSL's H1 result but analysts focus on an improving plasma product margin and solid growth ...
Top doctors raised concerns about domestically made drugs, saying Beijing’s effort to lower costs is sacrificing quality. By Alexandra Stevenson and Zixu Wang Reporting from Hong Kong A rare ...
It’s time to move on from treating heroin as Europe’s main drug problem, according to the head of the European Union’s drugs agency. That’s not to say heroin isn’t still a major problem.
Criticism over how the Chinese government buys drugs for its public health care system has ignited frustration over the quality of medicine. By Alexandra Stevenson and Zixu Wang Reporting from ...
The drug she received — a new kind of analgesic being tested in a clinical trial — eased her discomfort, without the grogginess or nausea of opioids. “I felt very lucid,” says Vairin ...
Specialty products were down 5% where the loss of a substantial contract for KCENTRA saw its sales decline by 20% in the period. Despite the loss of this contract, KCENTRA remains the clear market ...
The authors surveyed nearly 350 people about how many attempts it took to quit a substance before they were finally able to maintain their sobriety - revealing which drugs could be the most addicting.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results